Company news
FluoGuide A/S news in 2026
FluoGuide A/S's news releases, calls and decks from 2026, newest first.
FluoGuide Enrolls First Patient in U.S. Phase 2 Trial of FG001 in High-Grade Glioma
October 5, 2026
FluoGuide Enters Collaboration with Leica Microsystems, a World Leading Medical Technology Company
October 2, 2026
FluoGuide A/S publishes interim report for Q2 2026
August 25, 2026
Invitation to FluoGuide A/S live webcast on 25 August 2026
August 12, 2026
FluoGuide A/S publishes interim report for Q1 2026
May 27, 2026
Invitation to FluoGuide A/S live webcast on 27 May 2026
May 13, 2026
FluoGuide Receives FDA Fast Track Designation for FG001 in High-Grade Glioma
March 18, 2026
Notice of Annual General Meeting in FluoGuide A/S
March 10, 2026
FluoGuide A/S Publishes Annual Report For The Fiscal Year 2025
February 25, 2026
FluoGuide A/S Publishes Interim Report For Q4 2025
February 25, 2026
FDA Clears FluoGuide's IND for FG001 in High-Grade Glioma; U.S. Clinical Trial Remains on Track
February 20, 2026
Invitation to FluoGuide A/S (Nasdaq: FLUO) Live Webcast on 25 February 2026
February 19, 2026
FluoGuide Submits an IND for FG001, to Initiate First U.S. Registration Trial
January 21, 2026
Decks in 2026
- Investor Presentation (January 2026)
Investor deck · 11 slides · Jan 21, 2026